L26/P-417 Diminished Ovarian Reserve and Fertility Preservation: the Dilemma. Stratification improves outcomes in a real-world cohort study
Human Reproduction · 01.07.2026 · 41 (Supplement_1)
DOI: 10.1093/humrep/deag083.751 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Human Reproduction, online erschienen am 08.07.2026. Verfasst von M.E. Coccia und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Study question Should all women with diminished ovarian reserve (DOR) be offered fertility preservation (FP), or does stratification improve counseling and decision-making in clinical practice? Summary answer Stratifying women with DOR by anti-Müllerian hormone (AMH) levels and age reveals significant differences in FP outcomes supporting individualized counseling. What is known already DOR patients represent a challenging population, as reaching the 10–15 vitrified oocytes generally considered a reasonable target for FP remains difficult. However, outcomes within this group can vary, suggesting underlying heterogeneity. In the ART setting, stratification models have been developed to classify patients at risk of poor prognosis, a concept closely related to DOR. These models typically combine AMH with other clinical parameters. However, no such models exist specifically for FP setting, where clinical goals and success metrics differ. It remains unclear which DOR patients may benefit from FP, and which parameters should guide individualized clinical decisions. Study design, size, duration This prospective single-center cohort study was conducted between January 2016 and September 2025. Eligible patients were women aged ≤ 40 years with DOR undergoing FP via oocyte cryopreservation. Exclusion criteria included lack of informed consent and discontinuation of FP process prior to oocyte retrieval. Overall, 148 patients were included and stratified into two AMH-based cohorts (Cohort 1: <0.5 vs Cohort 2: 0.6–1.1 ng/mL), according to commonly cited cutoffs in the literature. Participants/materials, setting, methods Patients underwent controlled ovarian stimulation and oocyte vitrification according to standardized clinical protocols. Primary outcomes were the number of retrieved oocytes (RO) and vitrified metaphase II oocytes (VO). Comparisons between cohorts were performed using non-parametric statistical tests. Stimulation characteristics—including duration, total and daily gonadotropin dosages—were also analyzed. Subanalyses were conducted to explore the impact of age in both cohorts. Main results and the role of chance Cohort 1 (AMH <0.5 ng/mL) included 73 patients, while Cohort 2 (AMH 0.6–1.1 ng/mL) included 75 patients. Despite comparable age between cohorts (32.7 ± 5.1 vs 32.6 ± 5.6 years, p = 0.763), and a higher gonadotropin consumption in Cohort 1 (p ≤ 0.012), oocyte yields were significantly higher in Cohort 2: 4.9 ± 3.8 RO, representing a mean increase of 1.5 RO compared to Cohort 1 (3.4 ± 2.5, p = 0.003); and 4.3 ± 3.3 VO, representing a mean increase of 1.8 VO compared to Cohort 1(2.5 ± 2.1, p < 0.001). In a subgroup analysis of Cohort 1, patients aged ≤33 years yielded significantly more VO than older patients (3.5 ± 2.6 vs 2.1 ± 1.6, p = 0.013), whereas RO were not significantly higher (p = 0.167). Despite overall low yields, the observed differences may be clinically meaningful: in this challenging population, even a small increase in oocyte yield could impact reproductive potential. Our findings suggest that FP may be clinically appropriate in patients with low—but not critical—ovarian reserve, potentially through two-three stimulation cycles, including strategies such as DuoStim. In cases of severe DOR, careful selection (e.g., based on age) appears warranted to guide clinical decisions. Limitations, reasons for caution This was a single-center, observational study with a limited sample size and no long-term follow-up. Results refer to intermediate outcomes only, and data on use of vitrified oocytes and pregnancies are not yet available. Findings may not be generalizable to all DOR patients or to different clinical contexts. Wider implications of the findings Our findings support personalized, evidence-based FP counseling providing realistic expectations. They may contribute to developing FP-specific stratification models. In severe DOR, FP may be mainly appropriate in younger women. Early AMH monitoring may be useful, as well as multiple cycles or DuoStim. Further studies are needed to define optimal strategies. Trial registration number No
Zitieren
APA
Coccia, M., & Gabbrielli, B. (2026). L26/P-417 Diminished Ovarian Reserve and Fertility Preservation: the Dilemma. Stratification improves outcomes in a real-world cohort study. Human Reproduction, 41(Supplement_1). https://doi.org/10.1093/humrep/deag083.751
Vancouver
Coccia M, Gabbrielli B. L26/P-417 Diminished Ovarian Reserve and Fertility Preservation: the Dilemma. Stratification improves outcomes in a real-world cohort study. Human Reproduction. 2026;41(Supplement_1). doi:10.1093/humrep/deag083.751
BibTeX
@article{Coccia2026,
author = {Coccia, M.E. and Gabbrielli, B.},
title = {L26/P-417 Diminished Ovarian Reserve and Fertility Preservation: the Dilemma. Stratification improves outcomes in a real-world cohort study},
journal = {Human Reproduction},
year = {2026},
volume = {41},
number = {Supplement_1},
doi = {10.1093/humrep/deag083.751}
}
EUVIMED